Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siming Li

Showing results (181-190 of 250) with videos related to

Pageof 25
Sort By:
The British Journal of Dermatology|January 23, 2023
Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapyLi Zhou, Lizhi Shao, Shunyu Gao, et al.
Frontiers in Oncology|October 29, 2020
The Impact of Liver Metastasis on Anti-PD-1 Monoclonal Antibody Monotherapy in Advanced Melanoma: Analysis of Five Clinical StudiesXuan Wang, Qing Ji, Xieqiao Yan, et al.
Chinese Clinical Oncology|September 6, 2018
Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case reportBixia Tang, Xinan Sheng, Yan Kong, et al.
The Journal of Clinical Investigation|May 1, 2026
THEMIS attenuates MASH by suppressing disease-associated hepatocyte induction and hepatocyte senescence in miceXiaoxue Qiu, You Lu, Yuwei Tang, et al.
Urologic Oncology|June 30, 2022
Clinicopathological characteristics and prognosis of metastatic collecting duct carcinomaLi Zhou, Yiqiang Liu, Jiazhi Mo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2017
<i>MAPK</i> Pathway and <i>TERT</i> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 CasesXue Bai, Yan Kong, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2016
GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosisXinan Sheng, Yan Kong, Yiqian Li, et al.
Translational Oncology|July 30, 2018
Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment FailureChuanLiang Cui, Li Zhou, Bin Lian, et al.
Frontiers in Pharmacology|December 3, 2021
Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical StudiesHui Tian, Xuan Wang, Bin Lian, et al.
Diabetes|January 1, 2014
Otopetrin 1 protects mice from obesity-associated metabolic dysfunction through attenuating adipose tissue inflammationGuo-Xiao Wang, Kae Won Cho, Maeran Uhm, et al.
Pageof 25

Showing results (181-190 of 250) with videos related to

Sort By:
Pageof 25
The British Journal of Dermatology|January 23, 2023
Impact of response patterns for patients with advanced acral melanoma treated with anti-programmed death-1 monotherapyLi Zhou, Lizhi Shao, Shunyu Gao, et al.
Frontiers in Oncology|October 29, 2020
The Impact of Liver Metastasis on Anti-PD-1 Monoclonal Antibody Monotherapy in Advanced Melanoma: Analysis of Five Clinical StudiesXuan Wang, Qing Ji, Xieqiao Yan, et al.
Chinese Clinical Oncology|September 6, 2018
Palbociclib for treatment of metastatic melanoma with copy number variations of CDK4 pathway: case reportBixia Tang, Xinan Sheng, Yan Kong, et al.
The Journal of Clinical Investigation|May 1, 2026
THEMIS attenuates MASH by suppressing disease-associated hepatocyte induction and hepatocyte senescence in miceXiaoxue Qiu, You Lu, Yuwei Tang, et al.
Urologic Oncology|June 30, 2022
Clinicopathological characteristics and prognosis of metastatic collecting duct carcinomaLi Zhou, Yiqiang Liu, Jiazhi Mo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2017
<i>MAPK</i> Pathway and <i>TERT</i> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 CasesXue Bai, Yan Kong, Zhihong Chi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 8, 2016
GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosisXinan Sheng, Yan Kong, Yiqian Li, et al.
Translational Oncology|July 30, 2018
Safety and Efficacy of Apatinib Combined with Temozolomide in Advanced Melanoma Patients after Conventional Treatment FailureChuanLiang Cui, Li Zhou, Bin Lian, et al.
Frontiers in Pharmacology|December 3, 2021
Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical StudiesHui Tian, Xuan Wang, Bin Lian, et al.
Diabetes|January 1, 2014
Otopetrin 1 protects mice from obesity-associated metabolic dysfunction through attenuating adipose tissue inflammationGuo-Xiao Wang, Kae Won Cho, Maeran Uhm, et al.
Pageof 25